MARK2 and colon carcinoma: The EGFR transactivation by PAR1 or PAR2 leading to COX-2 expression [124], enhanced cell proliferation in colon carcinoma cells [112,113] and cell migration in renal carcinoma cells [111] is dependent on matrix metalloproteinase (MMP) activity.